{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:04:32Z","timestamp":1789380272103,"version":"build-2803163510"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Electrolyte disorders are highly prevalent in critically ill patients and have been associated with severe clinical manifestations, including cardiac arrhythmia and increased mortality. In the context of allogeneic hematopoietic cell transplantation (HCT), graft-versus-host disease (GVHD), acute kidney injury (AKI), and the use of emetogenic conditioning regimens, calcineurin inhibitors, amphotericin B, foscarnet, diuretics, among other drugs, may contribute to the development of complex and interrelated electrolyte disturbances. However, studies addressing the incidence, severity, and clinical relevance of these electrolyte imbalances in allogeneic HCT recipients remain scarce. In addition, interindividual variability in calcineurin inhibitor exposure, partially influenced by pharmacogenetic factors such as\n                      <jats:italic>CYP3A5<\/jats:italic>\n                      polymorphisms, may contribute to differences in susceptibility to these disturbances.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine the frequency and severity of electrolyte disturbances in allogeneic HCT recipients and to evaluate potential pharmacogenetic-related factors associated with these alterations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective, single-center study included 374 patients who underwent allogeneic HCT and received tacrolimus or cyclosporine for graft-versus-host disease prophylaxis. Electrolyte disturbances involving potassium, sodium, magnesium, and calcium were defined according to laboratory reference values and graded using the Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. Clinical and transplant characteristics were obtained from electronic medical records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Electrolyte disturbances were highly prevalent, particularly those characterized by low serum concentrations, including hypocalcemia (86.6%), hypomagnesemia (85.6%), hyponatremia (75.7%), and hypokalemia (62.6%), whereas hypercalcemia was rare. Most disturbances were mild to moderate, although hypocalcemia, hyperkalemia, and hypokalemia accounted for a substantial proportion of severe cases. Electrolyte abnormalities frequently occurred concomitantly, demonstrating strong interdependence, especially among potassium, sodium and calcium. Acute kidney injury, total body irradiation, age, and concomitant electrolyte disturbances were identified as significant factors associated with these outcomes. No significant differences in the incidence or severity of disturbances were observed between tacrolimus and cyclosporine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Electrolyte disturbances after allogeneic HCT are common, often multifactorial, interdependent, and clinically relevant. These findings highlight the need for integrated monitoring and early management of electrolyte abnormalities in the post-transplant period.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1934354","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:20:31Z","timestamp":1789377631000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Electrolyte disturbances after allogeneic hematopoietic cell transplantation in patients receiving calcineurin inhibitors: incidence and severity"],"prefix":"10.3389","volume":"17","author":[{"given":"Maria Clara","family":"Ferreira Camargo","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Escola Paulista de Medicina, Universidade Federal de S\u00e3o Paulo (EPM-Unifesp)","place":["S\u00e3o Paulo, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Carlos da","family":"Costa-Junior","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplant Center, Instituto Nacional de C\u00e2ncer (INCA)","place":["Rio de Janeiro, Brazil"]},{"name":"Postgraduate Program in Medical Sciences, Faculdade de Medicina da Universidade de S\u00e3o Paulo (FMUSP)","place":["S\u00e3o Paulo, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Izu","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplant Center, Instituto Nacional de C\u00e2ncer (INCA)","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"de C\u00e1ssia Barbosa da Silva Tavares","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplant Center, Instituto Nacional de C\u00e2ncer (INCA)","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone Cunha","family":"Maradei Pereira","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplant Center, Instituto Nacional de C\u00e2ncer (INCA)","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias Hallack","family":"Atta","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplant Center, Instituto Nacional de C\u00e2ncer (INCA)","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Claudia","family":"Rodrigues Moreira","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplant Center, Instituto Nacional de C\u00e2ncer (INCA)","place":["Rio de Janeiro, Brazil"]},{"name":"Bone Marrow Transplant Program, Hospital Universit\u00e1rio Clementino Fraga Filho (HUCFF), Universidade Federal do Rio de Janeiro (UFRJ)","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Colares","family":"Nogueira","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplant Center, Instituto Nacional de C\u00e2ncer (INCA)","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9cio","family":"Lerner","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplant Center, Instituto Nacional de C\u00e2ncer (INCA)","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"de Souza Fernandez","sequence":"additional","affiliation":[{"name":"Cytogenetic Laboratory, Cell and Gene Therapy Program, Instituto Nacional de C\u00e2ncer (INCA)","place":["Rio de Janeiro, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Caleb","family":"J\u00fanior Lima Santos","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Escola Paulista de Medicina, Universidade Federal de S\u00e3o Paulo (EPM-Unifesp)","place":["S\u00e3o Paulo, Brazil"]},{"name":"Postgraduate Program in Medical Sciences, Faculdade de Medicina da Universidade de S\u00e3o Paulo (FMUSP)","place":["S\u00e3o Paulo, Brazil"]},{"name":"Faculty of Pharmaceutical Sciences, Federal University of Alfenas, Unifal-MG","place":["Minas Gerais, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"95905","DOI":"10.5500\/wjt.v14.i3.95905","article-title":"Disorders of potassium homeostasis after kidney transplantation","volume":"14","author":"Aboghanem","year":"2024","journal-title":"World J. Transpl."},{"key":"B2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/medsci7040056","article-title":"Magnesium: the forgotten electrolyte\u2014a review on hypomagnesemia","volume":"7","author":"Ahmed","year":"2019","journal-title":"Med. Sci. (Basel)."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.69849\/revistaft\/th10248181126","article-title":"Hydroelectrolytic disorders: sodium, potassium, calcium, and magnesium \u2013 a literature review","volume":"28","author":"Alexim","year":"2024","journal-title":"Rev. FT"},{"key":"B4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.resuscitation.2005.11.002","article-title":"Potassium disorders\u2014clinical spectrum and emergency management","volume":"70","author":"Alfonzo","year":"2006","journal-title":"Resuscitation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1161\/circ.102.suppl_1.i-217","article-title":"Part 8: advanced challenges in resuscitation \u2013 section 1: life-threatening electrolyte abnormalities","volume":"102","year":"2000","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/nep.13712","article-title":"Serum electrolyte dynamics in multiple myeloma patients undergoing autologous haematopoietic stem cell transplantation","volume":"25","author":"Anandan","year":"2020","journal-title":"Nephrol. Carlt."},{"key":"B7","doi-asserted-by":"publisher","first-page":"13943","DOI":"10.1038\/s41598-025-98677-7","article-title":"Electrolyte disorders in the critically ill: a retrospective analysis","volume":"15","author":"Bachmann","year":"2025","journal-title":"Sci. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.31053\/1853.0605.v74.n3.14766","article-title":"Hyponatremia induced by high-dose cyclophosphamide therapy: a retrospective cohort study","volume":"74","author":"Bonella","year":"2017","journal-title":"Rev. Fac. Cien Med. Univ. Nac. Cordoba"},{"key":"B9","first-page":"192","article-title":"Cyclophosphamide-induced symptomatic hyponatraemia","volume":"69","author":"Bruining","year":"2011","journal-title":"Neth J. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1569353","DOI":"10.3389\/fphar.2025.1569353","article-title":"Polymorphisms in CYP3A5, CYP3A4, and ABCB1 genes: implications for calcineurin inhibitors therapy in hematopoietic cell transplantation recipients\u2014a systematic review","volume":"16","author":"Da Costa-Junior","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B11","first-page":"471","article-title":"Effect of cyclosporine A on Na+\/K(+)-ATPase, Na+\/K+\/2Cl\u2212 cotransporter, and H+\/K(+)-ATPase in MDCK cells and two subtypes, C7 and C11","volume":"5","author":"Deppe","year":"1997","journal-title":"Exp. Nephrol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1210\/endo.143.5.8821","article-title":"Cyclosporine A and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation","volume":"143","author":"Deppe","year":"2002","journal-title":"Endocrinology"},{"key":"B13","first-page":"51","article-title":"Serum electrolyte changes at engraftment time in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"14","author":"Faghihi","year":"2009","journal-title":"Ann. Transpl."},{"key":"B14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.ackd.2019.08.006","article-title":"The many faces of calcineurin inhibitor toxicity\u2014What the FK?","volume":"27","author":"Farouk","year":"2020","journal-title":"Adv. Chronic Kidney Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.46765\/2675-374X.2023v4n1p188","article-title":"VI consensus of the Brazilian society of bone marrow transplantation (SBTMO): consensus on graft-versus-host disease (GVHD)","volume":"4","author":"Funke","year":"2023","journal-title":"J. Bone Marrow Transpl. Cell Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jaccao.2024.06.004","article-title":"Cardiovascular disease after hematopoietic stem cell transplantation in adults: JACC: cardiooncology state-of-the-art review","volume":"6","author":"Gent","year":"2024","journal-title":"JACC CardioOncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1345\/aph.1R296","article-title":"Syndrome of inappropriate antidiuretic hormone secretion induced by a single dose of oral cyclophosphamide","volume":"46","author":"Gilbar","year":"2012","journal-title":"Ann. Pharmacother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1046\/j.1399-0012.2003.00154.x","article-title":"Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression","volume":"18","author":"Heering","year":"2004","journal-title":"Clin. Transpl."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0204914","DOI":"10.1371\/journal.pone.0204914","article-title":"Early and late complications following hematopoietic stem cell transplantation in pediatric patients \u2013 a retrospective analysis over 11 years","volume":"13","author":"Hierlmeier","year":"2018","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/ndt\/gfg515","article-title":"Hyponatraemia and hyperkalaemia are more frequent in renal transplant recipients treated with tacrolimus than with cyclosporin","volume":"19","author":"Higgins","year":"2004","journal-title":"Nephrol. Dial. Transpl."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1681\/ASN.2007070792","article-title":"Mechanism of hypokalemia in magnesium deficiency","volume":"18","author":"Huang","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1781484","DOI":"10.3389\/fcvm.2026.1781484","article-title":"Atrial fibrillation post hematopoietic stem cell transplant: incidence, risk factors, and management challenges","volume":"13","author":"Kawtharany","year":"2026","journal-title":"Front. Cardiovasc Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/sj.bmt.1705599","article-title":"Acute renal failure after allogeneic myeloablative stem cell transplantation","volume":"39","author":"Kersting","year":"2007","journal-title":"Bone Marrow Transpl."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.6","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Int. Suppl."},{"key":"B25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.17925\/EE.2020.16.2.122","article-title":"Anticancer medications and sodium dysmetabolism","volume":"16","author":"Krishnamurthy","year":"2020","journal-title":"Eur. Endocrinol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.5049\/EBP.2007.5.2.126","article-title":"Electrolyte and acid-base disturbances induced by calcineurin inhibitors","volume":"5","author":"Lee","year":"2007","journal-title":"Electrolyte Blood Press"},{"key":"B27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.bmt.1704708","article-title":"Severe metabolic abnormalities after allogeneic hematopoietic cell transplantation","volume":"35","author":"Lee","year":"2005","journal-title":"Bone Marrow Transpl."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1093\/ndt\/gfp657","article-title":"Hyponatraemia induced by low-dose intravenous pulse cyclophosphamide","volume":"25","author":"Lee","year":"2010","journal-title":"Nephrol. Dial. Transpl."},{"key":"B29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.amjmed.2012.06.037","article-title":"Electrolyte disorders in community subjects: prevalence and risk factors","volume":"126","author":"Liamis","year":"2013","journal-title":"Am. J. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/jof7050347","article-title":"Breakthrough invasive fungal infections in allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Liberatore","year":"2021","journal-title":"J. Fungi (Basel)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1159\/000103213","article-title":"Early renal injury after nonmyeloablative allogeneic peripheral blood stem cell transplantation in patients with chronic myelocytic leukemia","volume":"27","author":"Liu","year":"2007","journal-title":"Am. J. Nephrol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/ki.1987.222","article-title":"Serum magnesium level and arterial calcification in end-stage renal disease","volume":"32","author":"Meema","year":"1987","journal-title":"Kidney Int."},{"key":"B33","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B34","volume-title":"Common Terminology Criteria for Adverse Events (CTCAE). Version 5.0","year":"2017"},{"key":"B35","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/01.asn.0000113318.56023.b6","article-title":"Downregulation of Ca(2+) and Mg(2+) transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia","volume":"15","author":"Nijenhuis","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.2215\/cjn.08580813","article-title":"Regulation of potassium homeostasis","volume":"10","author":"Palmer","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"eAE4799","DOI":"10.31744\/einstein_journal\/2020AE4799","article-title":"Brazilian nutritional consensus in hematopoietic stem cell transplantation: graft-versus-host disease","volume":"18","author":"Pereira","year":"2020","journal-title":"Einstein (Sao Paulo)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/ndt\/gfm571","article-title":"Incidence and severity of early electrolyte abnormalities following autologous haematopoietic stem cell transplantation","volume":"23","author":"Philibert","year":"2008","journal-title":"Nephrol. Dial. Transpl."},{"key":"B39","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fmed.2018.00261","article-title":"Electrolyte and acid-base disorders in the renal transplant recipient","volume":"5","author":"Pochineni","year":"2018","journal-title":"Front. Med. (Lausanne)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"259","DOI":"10.46765\/2675-374x.2025v6n1p259","article-title":"Current use and outcomes of hematopoietic cell transplantation: brazilian summary slides \u2013 2025","volume":"6","author":"Simione","year":"2025","journal-title":"J. Bone Marrow Transpl. Cell Ther."},{"key":"B41","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-031-44080-9","volume-title":"The EBMT Handbook: Hematopoietic Cell Transplantation and Cellular Therapies","author":"Sureda","year":"2024"},{"key":"B42","first-page":"47","article-title":"Magnesium metabolism and its disorders","volume":"24","author":"Swaminathan","year":"2003","journal-title":"Clin. Biochem. Rev."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13097","article-title":"Calcineurin inhibitor-associated electrolyte disturbances after pediatric renal transplantation: could fludrocortisone therapy have a role?","volume":"22","author":"Tainio","year":"2018","journal-title":"Pediatr. Transpl."},{"key":"B44","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/ki.1993.38","article-title":"Nephron segment-specific inhibition of Na+\/K(+)-ATPase activity by cyclosporin A","volume":"43","author":"Tumlin","year":"1993","journal-title":"Kidney Int."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e14778","DOI":"10.1111\/petr.14778","article-title":"Calcineurin inhibitor-related hyperkalemia is caused by hyporeninemic hypoaldosteronism and fludrocortisone is an effective treatment: report of a case series and review of the literature","volume":"28","author":"Unsal","year":"2024","journal-title":"Pediatr. Transpl."},{"key":"B46","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/jof6040385","article-title":"Safety and efficacy of intermittent high-dose liposomal amphotericin B antifungal prophylaxis in haemato-oncology: an eight-year single-centre experience and review of the literature","volume":"6","author":"Youngs","year":"2020","journal-title":"J. Fungi (Basel)"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1934354\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:20:33Z","timestamp":1789377633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1934354\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":46,"alternative-id":["10.3389\/fphar.2026.1934354"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1934354","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"article-number":"1934354"}}